Main > HEPATOLOGY > Hepatitis C Virus Infection > Treatment > Co: USA. M. Elbasvir+Grasoprevir
Co: USA. M. Elbasvir+Grasoprevir's subsections
(*) EU Approval Date: 2016. 07.29.
(*) USA Approval Date: 2016. 01.28.
Company
Elbasvir: NS5A Inh.
Grazoprevir: NS3/4A Protease Inh.
TradeMark
TradeMark Web-Site
Co: USA. M. Elbasvir+Grasoprevir's products
This section has no products